Company Filing History:
Years Active: 2013
Title: Serena Debo: Innovator in Tumor Immunotherapy
Introduction
Serena Debo is a prominent inventor based in Mainz, Germany. She has made significant contributions to the field of tumor immunotherapy, particularly in the development of individualized therapeutic vaccines for cancer patients. Her innovative approach focuses on harnessing the body's immune response to target tumor-associated antigens.
Latest Patents
Serena Debo holds a patent for her invention titled "Detection of individual T-cell reaction patterns against tumor-associated antigens (TAA) in tumor patients as a basis for the individual therapeutic vaccination of patients." This patent outlines a method for identifying preferential target antigens of antitumoral T-cells from tumor patients. The process involves providing T-cells from the blood of patients, using autologous dendritic cells and/or B-lymphocytes that have been transfected with mRNAs encoding TAA, and identifying T-cells that recognize these antigens. The invention also includes methods for producing individualized tumor vaccines and therapeutic treatments for cancer.
Career Highlights
Throughout her career, Serena has worked at esteemed institutions, including Johannes Gutenberg University Mainz. Her research has focused on advancing the understanding of immune responses in cancer patients, leading to innovative therapeutic strategies.
Collaborations
Serena has collaborated with notable colleagues, including Martina Fatho and Emmanuelle Wesarg, contributing to the advancement of cancer immunotherapy research.
Conclusion
Serena Debo's work in tumor immunotherapy exemplifies the potential of personalized medicine in treating cancer. Her innovative methods and dedication to research continue to pave the way for advancements in individualized cancer treatments.